Home > About

Extract Value from Natural and Chemically Modified Compounds


Pre-clinical porfolio of microbiome-derived immune-modulating peptides with exclusive technologies and the sicnetific expertise for discovering, expanding and advancing a valuable IO/I pipeline.


Primary Strategy:

  • • Deep dive into metabolome
    • • Concentratio if minor metabolites
    • • Fractionanation to simplified pools for testing
    • • High rate of structured novelty
    • • Priority driven by biological activity (IP created)
    • • Potential to go directly to the organism

    Derivative strategy:

    • • Modify major metabolites
    • • Novel chemistry creates IP positions
    • • Abundant by-product compounds
    • • One-step chemistry transforms ADME properties
    • • Available for broad screening as pure compounds
    • • Synthetic GMP (IP creates)











Pin It on Pinterest